DBVT Q3 2023 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$455,635

Operating Income

-$21M

Net Income

-$17M

EPS (Diluted)

$-0.85

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$190M

Total Liabilities

$46M

Stockholders' Equity

$144M

Cash & Equivalents

$149M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$455,635	-$3M	+83.2%
Operating Income	-$21M	-$20M	-2.7%
Net Income	-$17M	-$17M	+3.2%